• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

Introduction to (Z)-2-Fluoro-N-hydroxybenzene-1-carbonimidoyl chloride (CAS No. 1402390-94-6)

Chemical compounds play a pivotal role in the advancement of pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Among these, (Z)-2-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride (CAS No. 1402390-94-6) stands out as a versatile intermediate with significant applications in medicinal chemistry. This compound, characterized by its unique structural and functional attributes, has garnered attention for its potential in designing innovative drug molecules.

The molecular structure of (Z)-2-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride encompasses a fluorinated aromatic ring connected to a carbonimidoyl chloride moiety. The presence of the fluorine atom at the 2-position enhances the electronic properties of the benzene ring, making it more susceptible to nucleophilic substitution reactions. This feature is particularly valuable in the synthesis of biologically active compounds, where fluorine atoms are often incorporated to improve metabolic stability and binding affinity.

In recent years, there has been a surge in research focused on developing fluorinated heterocycles as pharmacophores. The carbonimidoyl chloride functional group in this compound serves as a reactive handle for further derivatization, enabling the construction of complex molecular architectures. This reactivity has been leveraged in the synthesis of various pharmacologically relevant scaffolds, including kinase inhibitors and antiviral agents.

One of the most compelling aspects of (Z)-2-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride is its utility in cross-coupling reactions. The combination of a fluoro-substituted benzene ring and a carbonimidoyl chloride group makes it an ideal candidate for palladium-catalyzed reactions such as Suzuki-Miyaura and Heck couplings. These transformations have been widely employed in the construction of biaryl structures, which are prevalent in many approved drugs due to their favorable pharmacokinetic properties.

Recent studies have highlighted the role of fluorinated aromatic compounds in modulating enzyme activity. For instance, (Z)-2-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride has been investigated as a potential scaffold for developing inhibitors targeting enzymes involved in cancer metabolism. The electron-withdrawing nature of the carbonimidoyl chloride group facilitates precise tuning of the compound's reactivity, allowing for selective interactions with biological targets.

The pharmaceutical industry has also explored the use of this compound in designing protease inhibitors. Proteases are critical enzymes involved in various physiological processes, and their dysregulation is often associated with diseases such as cancer and inflammation. By incorporating fluorine atoms into protease inhibitors, researchers aim to enhance their binding affinity and reduce susceptibility to degradation by metabolic enzymes. The carbonimidoyl chloride moiety provides a site for covalent bond formation with catalytic residues on the enzyme surface, leading to potent inhibition.

Another area where (Z)-2-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride has shown promise is in antiviral drug development. Viruses often rely on host cellular machinery for replication, making them vulnerable to therapeutic intervention at multiple stages of their life cycle. Fluorinated compounds have demonstrated efficacy in disrupting viral replication by interfering with essential enzymatic processes. The structural features of this compound make it an attractive candidate for designing novel antiviral agents that can evade viral resistance mechanisms.

The synthesis of (Z)-2-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride involves multi-step organic transformations that highlight its synthetic versatility. Starting from commercially available precursors, such as fluoroanilines and chloroacetonitrile derivatives, researchers can construct the target molecule through a series of nucleophilic substitutions, condensations, and cyclizations. The use of modern catalytic methods has further streamlined these synthetic routes, making them more efficient and scalable.

In conclusion, (Z)-2-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride (CAS No. 1402390-94-6) is a valuable building block in medicinal chemistry with broad applications across multiple therapeutic areas. Its unique structural features and reactivity make it an indispensable tool for drug discovery researchers aiming to develop innovative therapeutic agents. As our understanding of fluorinated compounds continues to evolve, so too will their role in addressing unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)